Allergan Inc AGN:NYSE
Education help is ON
Sector: Healthcare Industry: Biotechnology & Drugs
58.62 Arrow Down-0.03   -0.05% 1,239,540 Market data is delayed by at least 20 minutes.
Last Change  /  % Change Volume
Exclusive
Features
 
When you open a Scottrade account, you will be able to trade, add stocks to a watch list, set alerts and get real-time quotes. Or
 
1day |  5day |  6mo |  1yr |  5yr

Latest News Headlines for Allergan Inc

Saturday 11/14/2009 12:05 AM ET - Close-Up Media

Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, and Nippon Kayaku announced an exclusive collaboration for the development and commercialization of apaziquone in Asia.

Earlier Headlines - view recent headlines
--/--

Bid/Size

--/--

Ask/Size

58.13

Price Open

58.65

Previous Close

58.82

Day High

58.13

Day Low

0.98

Beta (5yr)

60.85/11/11/09

52wk High/Date

28.95/11/21/08

52wk Low/Date

17.8 Billion

Market Capitalization

303.9 Million

Shares Outstanding

39.98

Volatility Avg (1 Year)

1.3 Million

Avg Vol (10 day)

32.5x

P/E Ratio

1.80

EPS (TTM)

0.05 (11/30/09)

Declared QRTR Div explain

0.34%

Yield

11/5/2009

Ex-Date

Scottrade Customers

Get the following exclusive content at no additional cost with your Scottrade account:

  • Standard & Poor's STARS Rating for the featured stock
  • Research reports from Reuters and Standard & Poor's
  • Market Edge Second Opinion Weekly Report

For full analysis, Open an Account or Log In with Scottrade

Allergan Inc vs. Peers

Company Market Cap YTD Price Performance
AGN

Allergan Inc

17.8B
+45.4%
ACL

Alcon, Inc.

43.4B
+62.9%
PFE

Pfizer Inc.

148.2B
+3.7%
MRK

Merck & Co., Inc.

111.4B
+19.9%
MRX

Medicis Pharmaceutical Corporation

1.4B
+69.0%

Company Background

Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices. The Company is engaged in discovering, developing and commercializing specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in more than 100 countries globally. In January 2007, the Company completed the acquisition of Groupe Corneal Laboratoires (Corneal). In October 2007, the Company completed the acquisition of Esprit Pharma Holding Company, Inc. (Esprit). In July 2008, the Company acquired the Aczone (dapsone) gel 5% from QLT USA, Inc. (QLT), a wholly owned subsidiary of QLT Inc. The Company operates in two business segments: specialty pharmaceuticals and medical devices.

© 2008 Scottrade

Brokerage Products and Services offered by Scottrade, Inc. - Member FINRA and SIPC

Online market and limit stock trades are just $7 for stocks priced $1 and above.

Any specific securities, or types of securities, used as examples are for demonstration purposes only. No information on this Web site should be considered a recommendation or None of the information provided should be considered a recommendation or solicitation to invest in, or liquidate, a particular security or type of security.

Investors should consider the investment objectives, risks, and charges and expenses of a mutual fund carefully before investing. A mutual fund's prospectus contains this and other information about the mutual fund. Prospectuses are available through our trading site or through a Scottrade branch office. The prospectus should be read carefully before investing. No transaction fee (NTF) funds are subject to the terms and conditions of the NTF funds program. Scottrade is compensated by the funds participating in the NTF program through recordkeeping, shareholder, or SEC 12b-1 fees.

Investors should consider the investment objectives, charges, expense, and unique risk profile of an Exchange Traded Fund (ETF) carefully before investing. Leveraged and Inverse ETFs may not be suitable for long-term investors and may increase exposure to volatility through the use of leverage, short sales of securities, derivatives and other complex investment strategies. A prospectus contains this and other information about the ETF and should be obtained from the issuer. The prospectus should be read carefully before investing.

Margin trading involves interest charges and risks, including the potential to lose more than deposited, or the need to deposit additional collateral in a falling market. Margin Disclosure Statement (PDF) is available for download, or it is available at one of our branch offices. It contains information on our lending policies, interest charges, and the risks associated with margin accounts.

Options involve risk and are not appropriate for all investors. Detailed information about the risks associated with options can be found in the Scottrade Options Application and Agreement, Brokerage Account Agreement, or by downloading the Characteristics and Risks of Standardized Options and Supplements (PDF) from The Options Clearing Corporation, or by requesting a copy from your local branch office. Supporting documentation for any claims will be supplied upon request.

Market volatility, volume, and system availability may impact account access and trade execution.

Testimonials may not be representative of the experience of other clients and are no guarantee of future performance or success.